1Oehler MK, MacKenzie IZ, Wallwienerc D, et al. Wnt- 7ais upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen - induced endometrial neoplasia [ J ]. Cancer Lett, 2002;
2Staid - Koopman E, Blok I J, Helmerhorst TJ, et al. Gene expression profiles of human endometrial cancer samples using a cDNA - expression array technique: assessment of an analysis method [J]. Br J Cancer,2000;83(2) :246 ～ 51
3Sugiyamad Y, Dan S, Yoshida Y, et al. A large - scale gene expression comparison of microdissected, small - sizedendometrial cancers with or without hyperplasia matched to same - patient normal tissue[J]. Cinical Cancer Research, 2003;9:5589 ～ 5600
4Alon U, Barkai N, Notterman DA, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays [J]. Proc Natl Acad Sci, 1999;96(12) :6745 ～ 6750
5Pecorelli S, Benedet JL, Creasman WT, et al. FIGO staging of gynecologic cancer. 1994 ～ 1997 FIGO committe on gynecologic oncology.International federation of gynecology and obsterics [ J]. Int J Gynaecol Obstet, 1999;65(3) :243 ～ 9
6Smid- Koopman E, Blok LJ, Helmerhorst TJ, et al. Gene expression profiling in human endometrial cancer tissue samples: utility and diagnostic value [J]. Gynecol Oncol, 2004;93(2):292- 300
7Matsushima - Nishiu M, Unoki M, Ono K, et al. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN [J]. Cancer Res, 2001 ;61 (9) :3741 - 3749
8Raetz EA, Moos PJ. Impact of microarray technology in clinical oncology [J]. Cancer Invest, 2004;22(2) :312 - 320
9Tanaka T, Tanimoto K, Otani K, et al. Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes [J]. Int J Cancer, 2004;111(4) :617- 26
10Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular - based classification [J].Virchows Arch, 2004;444(3) :213 - 223
